Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 3
1999 4
2000 5
2001 7
2002 3
2003 5
2004 10
2005 7
2006 9
2007 9
2008 14
2009 13
2010 12
2011 7
2012 19
2013 20
2014 13
2015 14
2016 17
2017 29
2018 27
2019 25
2020 18
2021 20
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

285 results
Results by year
Filters applied: . Clear all
Page 1
Diaphragm: Pathophysiology and Ultrasound Imaging in Neuromuscular Disorders.
Fayssoil A, Behin A, Ogna A, Mompoint D, Amthor H, Clair B, Laforet P, Mansart A, Prigent H, Orlikowski D, Stojkovic T, Vinit S, Carlier R, Eymard B, Lofaso F, Annane D. Fayssoil A, et al. Among authors: laforet p. J Neuromuscul Dis. 2018;5(1):1-10. doi: 10.3233/JND-170276. J Neuromuscul Dis. 2018. PMID: 29278898 Free PMC article. Review.
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
Solé G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, Adams D, Laforet P, Tiffreau V, Desguerre I, Pisella LI, Molon A, Attarian S; FILNEMUS COVID-19 study group. Solé G, et al. Among authors: laforet p. Rev Neurol (Paris). 2020 Jun;176(6):507-515. doi: 10.1016/j.neurol.2020.04.004. Epub 2020 Apr 20. Rev Neurol (Paris). 2020. PMID: 32354651 Free PMC article.
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study.
Pena LDM, Barohn RJ, Byrne BJ, Desnuelle C, Goker-Alpan O, Ladha S, Laforêt P, Mengel KE, Pestronk A, Pouget J, Schoser B, Straub V, Trivedi J, Van Damme P, Vissing J, Young P, Kacena K, Shafi R, Thurberg BL, Culm-Merdek K, van der Ploeg AT; NEO1 Investigator Group. Pena LDM, et al. Among authors: laforet p. Neuromuscul Disord. 2019 Mar;29(3):167-186. doi: 10.1016/j.nmd.2018.12.004. Epub 2018 Dec 17. Neuromuscul Disord. 2019. PMID: 30770310 Free article. Clinical Trial.
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase.
Puzzo F, Colella P, Biferi MG, Bali D, Paulk NK, Vidal P, Collaud F, Simon-Sola M, Charles S, Hardet R, Leborgne C, Meliani A, Cohen-Tannoudji M, Astord S, Gjata B, Sellier P, van Wittenberghe L, Vignaud A, Boisgerault F, Barkats M, Laforet P, Kay MA, Koeberl DD, Ronzitti G, Mingozzi F. Puzzo F, et al. Among authors: laforet p. Sci Transl Med. 2017 Nov 29;9(418):eaam6375. doi: 10.1126/scitranslmed.aam6375. Sci Transl Med. 2017. PMID: 29187643 Free PMC article.
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.
Sentner CP, Hoogeveen IJ, Weinstein DA, Santer R, Murphy E, McKiernan PJ, Steuerwald U, Beauchamp NJ, Taybert J, Laforêt P, Petit FM, Hubert A, Labrune P, Smit GPA, Derks TGJ. Sentner CP, et al. Among authors: laforet p. J Inherit Metab Dis. 2016 Sep;39(5):697-704. doi: 10.1007/s10545-016-9932-2. Epub 2016 Apr 22. J Inherit Metab Dis. 2016. PMID: 27106217 Free PMC article.
A randomized study of alglucosidase alfa in late-onset Pompe's disease.
van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA. van der Ploeg AT, et al. Among authors: laforet p. N Engl J Med. 2010 Apr 15;362(15):1396-406. doi: 10.1056/NEJMoa0909859. N Engl J Med. 2010. PMID: 20393176 Free article. Clinical Trial.
Update on new muscle glycogenosis.
Laforêt P, Malfatti E, Vissing J. Laforêt P, et al. Curr Opin Neurol. 2017 Oct;30(5):449-456. doi: 10.1097/WCO.0000000000000484. Curr Opin Neurol. 2017. PMID: 28737584 Review.
[Sarcoglycanopathies: state of the art and therapeutic perspectives].
Fernández-Eulate G, Leturcq F, Laforêt P, Richard I, Stojkovic T. Fernández-Eulate G, et al. Among authors: laforet p. Med Sci (Paris). 2020 Dec;36 Hors série n° 2:22-27. doi: 10.1051/medsci/2020243. Epub 2021 Jan 11. Med Sci (Paris). 2020. PMID: 33427632 Free article. Review. French.
Whole-body muscle MRI in McArdle disease.
Tobaly D, Laforêt P, Stojkovic T, Behin A, Petit FM, Barp A, Bello L, Carlier P, Carlier RY. Tobaly D, et al. Among authors: laforet p. Neuromuscul Disord. 2021 Aug 5:S0960-8966(21)00584-8. doi: 10.1016/j.nmd.2021.07.397. Online ahead of print. Neuromuscul Disord. 2021. PMID: 34711478
Progress and challenges of gene therapy for Pompe disease.
Ronzitti G, Collaud F, Laforet P, Mingozzi F. Ronzitti G, et al. Among authors: laforet p. Ann Transl Med. 2019 Jul;7(13):287. doi: 10.21037/atm.2019.04.67. Ann Transl Med. 2019. PMID: 31392199 Free PMC article. Review.
285 results